KRAS and familial pancreatic carcinoma: Whilst loss of KRAS via SiRNA knockdown failed to suppress ERK phosphorylation in T47D cells (supporting the theory that this event can occur independently of KRAS activity) in a pancreatic cancer cell line, KRAS knockdown suppressed phospho-ERK activity suggesting that there may be heterogeneity in these pathways depending on tumor type.